Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0H0KB
|
||||
Former ID |
DAP000527
|
||||
Drug Name |
Riluzole
|
||||
Synonyms |
Rilutek; Riluzol; Riluzolum; Riluzole HCl; RP 54274; ALBB-006046; BF-37; PK-26124; R-116; RP-54274; Rilutek (TN); Riluzol [INN-Spanish]; Riluzole [USAN:INN]; Riluzolum [INN-Latin]; ZERO/001785; Amino-2 trifluoromethoxy-6 benzothiazole; Amino-2 trifluoromethoxy-6 benzothiazole [French]; Riluzole (JAN/USAN/INN); PK-26124, RP-54274, Rilutek, Riluzole; 2-Amino-6-(trifluoromethoxy)-benzothiazole; 2-Amino-6-(trifluoromethoxy)benzothiazole; 2-Amino-6-trifluoro-methoxybenzothiazole; 2-amino-6-(trifluoromethoxy)-1,3-benzothiazole; 2-amino-6-(trifluoromethoxy)benzo[d]thiazole; 2-amino-6-(trifluoromethoxyl)benzothiazole; 2-amino-6-trifluoromethoxybenzothiazole; 6-(trifluoromethoxy)-1,3-benzothiazol-2-amine; 6-(trifluoromethoxy)benzo[d]thiazol-2-amine; 6-Trifluoromethoxy-benzothiazol-2-ylamine; 6-trifluoromethoxybenzothiazole-2-yl-amine
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Anticonvulsants
|
||||
Company |
Sanofi-Aventis
|
||||
Structure |
Download2D MOL |
||||
Formula |
C8H5F3N2OS
|
||||
InChI |
InChI=1S/C8H5F3N2OS/c9-8(10,11)14-4-1-2-5-6(3-4)15-7(12)13-5/h1-3H,(H2,12,13)
|
||||
InChIKey |
FTALBRSUTCGOEG-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 1744-22-5
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
10139, 855844, 866566, 3158794, 7379879, 7735262, 7847840, 7980518, 8153119, 11111722, 11111723, 11113346, 11120296, 11120784, 11121272, 11466195, 11467315, 11484335, 11485690, 11488366, 12013649, 14773880, 17405620, 24278006, 26679689, 26751529, 29224139, 46508094, 47440015, 47515108, 47588789, 47810535, 47810536, 48034873, 48334245, 49698375, 49890627, 50100339, 50104104, 50104105, 53778170, 57322593, 57566695, 57641351, 74971764, 85089205, 85171908, 85231207, 85787918, 85788320
|
||||
SuperDrug ATC ID |
N07XX02
|
||||
SuperDrug CAS ID |
cas=001744225
|
||||
Target and Pathway | |||||
Target(s) | Voltage-gated sodium channel | Target Info | Blocker | [535611] | |
References | |||||
Ref 536648 | Emerging drugs for spinal cord injury. Expert Opin Emerg Drugs. 2008 Mar;13(1):63-80. | ||||
Ref 539472 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2326). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.